Stocks and Investing Stocks and Investing
Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021
Sun, February 21, 2021
Fri, February 19, 2021

Tejas Savant Maintained (TXG) at Buy with Increased Target to $215 on, Feb 19th, 2021


Published on 2024-10-27 15:41:46 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $145 to $215 on, Feb 19th, 2021.

Tejas has made no other calls on TXG in the last 4 months.



There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 1 agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020


These are the ratings of the 3 analyists that currently disagree with Tejas


  • Doug Schenkel of "Cowen & Co." Maintained at Buy with Increased Target to $200 on, Thursday, February 18th, 2021
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $240 on, Thursday, February 18th, 2021
  • Tycho Peterson of "JP Morgan" Maintained at Buy with Increased Target to $195 on, Thursday, February 18th, 2021